Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Share-based Compensation (IS): 2014-2025

Historic Share-based Compensation (IS) for MediWound (MDWD) over the last 8 years, with Jun 2025 value amounting to $844,000.

  • MediWound's Share-based Compensation (IS) rose 64.84% to $844,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.7 million, marking a year-over-year increase of 28.26%. This contributed to the annual value of $3.1 million for FY2024, which is 61.75% up from last year.
  • Latest data reveals that MediWound reported Share-based Compensation (IS) of $844,000 as of Q2 2025, which was up 64.84% from $512,000 recorded in Q2 2024.
  • MediWound's Share-based Compensation (IS)'s 5-year high stood at $844,000 during Q2 2025, with a 5-year trough of $252,000 in Q2 2022.
  • Moreover, its 3-year median value for Share-based Compensation (IS) was $665,500 (2023), whereas its average is $671,750.
  • Per our database at Business Quant, MediWound's Share-based Compensation (IS) slumped by 49.60% in 2022 and then skyrocketed by 182.54% in 2023.
  • Quarterly analysis of 5 years shows MediWound's Share-based Compensation (IS) stood at $390,000 in 2021, then slumped by 49.60% to $252,000 in 2022, then spiked by 182.54% to $712,000 in 2023, then fell by 28.09% to $512,000 in 2024, then surged by 64.84% to $844,000 in 2025.
  • Its Share-based Compensation (IS) stands at $844,000 for Q2 2025, versus $512,000 for Q2 2024 and $712,000 for Q2 2023.